HANNAH CAMPBELL: Open Payments
NPI 1558509612 · SEBRING, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,681 in 75 payments from 19 companies in 2025. Trend: 2023 $2,054 · 2024 $2,628 · 2025 $1,681
Food & beverage: $1,681
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 11 | $345 |
| Amgen Inc. | 15 | $296 |
| Xeris Pharmaceuticals, Inc. | 10 | $220 |
| Novo Nordisk Inc | 6 | $114 |
| Dexcom, Inc. | 4 | $90 |
| Tandem Diabetes Care, Inc. | 3 | $83 |
| Ascendis Pharma Endocrinology Inc | 3 | $80 |
| IBSA Pharma Inc. | 4 | $74 |
| Lilly USA, LLC | 3 | $57 |
| Calliditas Therapeutics US Inc. | 2 | $50 |
Products named: Korlym, KRYSTEXXA, RECORLEV, Ozempic, Dexcom G6 Transmitter, GVOKE HYPOPEN, t:slim X2 Insulin Pump with Control-IQ, Yorvipath.
Industry payments across FL — which companies pay providers there.
